Anti-TNFSF7/CD27L/CD70 Antibody (Vorsetuzumab mafodotin)
Catalog No.
F1130
Anti-TNFSF7/CD27L/CD70 Antibody (Vorsetuzumab mafodotin)
Featured Products
Vorsetuzumab mafodotin (SGN-75) is an antibody-drug conjugate (ADC) consisting of a humanized monoclonal antibody directed against the extracellular domain of the human CD70 molecule and a cytotoxic tubulin polymerization inhibitor. It is used to treat renal cell carcinoma.
146.1 kDa
Dry ice
1165741-01-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Vorsetuzumab mafodotin
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P32970
Human
MMAF
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized humanCD70-His at 2 ug/mL (30 μL/well) can bind Anti-TNFSF7/CD27L/CD70 Antibody (Vorsetuzumab mafodotin) with the EC50 of 0.007612 ug/mL.
TNFSF7 / CD27L / CD70
Please avoid freeze-thaw cycles.